Omeros (OMER) Operating Income (2010 - 2026)
Omeros (OMER) reported Operating Income of -$17.4 million for Q1 2026, up 50.18% on a YoY basis from -$11.6 million in Q1 2025, and up 40.09% sequentially from -$29.1 million in Q4 2025.
Omeros (OMER) Operating Income (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Operating Income data on file, last reported at -$17.4 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income rose 50.18% year-over-year to -$17.4 million; the trailing twelve-month figure through Mar 2026 stood at -$105.2 million (up 35.39% YoY), and the FY2025 full-year result was -$122.8 million, up 26.45% from the prior year.
- Operating Income grew to -$17.4 million in Q1 2026, from -$29.1 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$17.4 million in Q1 2026 to a low of -$59.2 million in Q2 2024.
- A 5-year average of -$37.4 million and a median of -$35.7 million in 2023 frame the typical range for Operating Income.
- Across the five-year window, Operating Income tumbled 44.64% in 2024 and jumped 50.18% in 2026, its largest moves.
- Tracing OMER's Operating Income over 5 years: stood at -$40.1 million in 2022, then grew by 0.93% to -$39.8 million in 2023, then gained by 16.12% to -$33.4 million in 2024, then increased by 12.81% to -$29.1 million in 2025, then surged by 40.09% to -$17.4 million in 2026.
- Business Quant data shows OMER's Operating Income at -$17.4 million in Q1 2026, -$29.1 million in Q4 2025, and -$26.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Omeros | 707.67 Mn | 707.67 Mn | 9.31 Mn | -17.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.42 Mn |
| Dec 31, 2025 | -29.08 Mn |
| Sep 30, 2025 | -26.39 Mn |
| Jun 30, 2025 | -32.35 Mn |
| Mar 31, 2025 | -34.97 Mn |
| Dec 31, 2024 | -33.36 Mn |
| Sep 30, 2024 | -35.41 Mn |
| Jun 30, 2024 | -59.16 Mn |
| Mar 31, 2024 | -39.03 Mn |
| Dec 31, 2023 | -39.77 Mn |
| Sep 30, 2023 | -48.15 Mn |
| Jun 30, 2023 | -40.90 Mn |
| Mar 31, 2023 | -35.71 Mn |
| Dec 31, 2022 | -40.14 Mn |
| Sep 30, 2022 | -50.77 Mn |
| Jun 30, 2022 | -37.44 Mn |
| Mar 31, 2022 | -35.05 Mn |
| Dec 31, 2021 | -42.89 Mn |
| Sep 30, 2021 | -39.83 Mn |
| Jun 30, 2021 | -45.61 Mn |